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Objectives: To examine whether PHGG added ORS reduce duration of diarrhoea, stool output and enhance weight gain.
Methods: In a double-blind controlled clinical trial, 126 malnourished children (weight for length/weight for age
< −3 Z-score with or without pedal edema), aged 6 – 36 months with acute diarrhoea <7 days were studied in two
treatment groups; 63 received modified WHO ORS (Na 75, K 40, Cl 87, citrate 7, glucose 90 mmol/L) with PHGG 15 g/L
(study group); 63 received modified WHO ORS without PHGG (control). Other treatments were similar in both groups.
The study protocol was approved by Ethics Committee of icddr,b; the study was carried out at the Dhaka Hospital.
Results: The mean duration of diarrhoea (h) was significantly shorter in children of the study group (Study vs. control,
mean ± SD, 57 ± 31 vs. 75 ± 39, p = 0.01). Although there was a trend in stool weight reduction in children receiving
ORS with PHGG (study vs. control, stool weight (g), mean ± SD; 1st 24 hour, 854.03 ± 532.15 vs. 949.11 ± 544.33, p = 0.32;
2nd 24 hour, 579.84 ± 466.01 vs. 761.26 ± 631.64, p = 0.069; 3rd 24 hour, 385.87 ± 454.09 vs. 495.73 ± 487.61, p = 0.196),
especially in 2nd 24 h period, the difference was not statistically significant. The mean time (day) to attain weight for
length 80% of NCHS median without edema was significantly shorter in the study group (study vs. control, mean ± SD,
4.5 ± 2.6 vs. 5.7 ± 2.8, p = 0.027).
Conclusion: PHGG added to ORS substantially reduced duration of diarrhoea. It also enhanced weight gain. Further
studies might substantiate to establish its beneficial effect.
Clinical trial registration number: NCT01821586
Keywords: Diarrhoea, Severe malnutrition, Children, Partially hydrolyzed guar gum (PHGG)Background
The median case fatality rate of severely malnourished
children has remained as high as 20 to 26% for many
years, despite improved understanding of the pathophysi-
ology and treatment of these children [1]. It only high-
lights the widespread failure to use treatments that have
been known for many years. However, there has been a* Correspondence: nhalam@icddrb.org
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ized protocol for the treatment of severely malnourished
children [2]. This standardized protocol prepared by
World Health Organization [3] addressed overall manage-
ment of severely malnourished children compiling the
existing recommended treatment guidelines such as ap-
propriate rehydration, infection control, appropriate feed-
ing and micronutrient supplementation. But, there is a
scope of further reducing the case fatality rate and en-
hance recovery from malnutrition by improving the treat-
ment of common associated illnesses such as diarrhoea.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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ation of illnesses, as well as to increased prevalence of pro-
longed illnesses [4]. Since diarrhoea is associated with
further loss of weight and deficiency of macro- and micro-
nutrients, early recovery along with lessening of diarrhoea
severity will help to prevent further weight loss and defi-
ciency of these nutrients in severely malnourished chil-
dren. Additionally, severely malnourished children have
depleted potassium stores, and diarrhoea further depletes
the serum potassium concentration [5]. Early recovery
from diarrhoea will prevent further deficits of serum po-
tassium concentration and total body stores.
Current recommended ORS containing salts and glu-
cose is effective in correcting dehydration even in se-
verely malnourished children. Efforts have been made to
further improve the efficacy of ORS in terms of reducing
the duration of diarrhoea and stool output. One study
[6] with WHO-ORS containing partially hydrolyzed guar
gum (PHGG) and another [7] PHGG supplemented
comminuted chicken diet have shown to reduce diar-
rhoea duration and stool output in children with acute
and persistent diarrhoea, respectively. PHGG is a soluble
fiber and its addition doesn’t alter the clarity of the solu-
tion, neither its taste. PHGG is produced by enzymatic
hydrolysis of guar gum which is obtained from guar
seed- one variety of legumes for use as a food additive
and as a source of dietary fiber [8]. The added PHGG in
the ORS or diet escapes digestion in the small intestine
and enter into the colon where the fibers are expected
to be fermented by colonic bacteria producing short
chain fatty acids (SCFAs) [9]. SCFAs will stimulate so-
dium and water absorption in the colon [10-12] leading
to early recovery from diarrhoea. In addition, SCFAs
have trophic effect in the colonic mucosa, which utilize
SCFAs as fuel thus enhancing nutritional recovery.
We hypothesized that the addition of PHGG to ORS
will enhance recovery from diarrhoea and malnutrition of
the severely malnourished children with acute diarrhoea.
In this study we have used the current WHO/UNICEF
recommended ORS formulation (Na+ 75) with increased
concentration of potassium (K+ 40) for a better alternative
in the management of severely malnourished children
with watery diarrhoea in terms of correcting hypokalemia
and preventing symptomatic hyponatraemia.
Methods
Study design
This was a randomized, double-blind, controlled clinical
trial to assess the efficacy of (i) modified WHO ORS plus
PHGG (Currently WHO recommended ORS with some
modification, Na 75 mmol/L, Cl 87 mmol/L, K 40 mmol/L,
citrate 7 mmol/L, Mg 3 mmol/L, Zn 300 μmol/L, Cu
45 μmol/L, glucose 90 mmol/L) plus PHGG 15 mmol/L -
Study group) compared with ii) modified WHO ORS (Na75 mmol/L, Cl 87 mmol/L, K 40 mmol/L, citrate 7 mmol/L,
Mg 3 mmol/L, Zn 300 μmol/L, Cu 45 μmol/L, glucose
90 mmol/L without PHGG - control group) in the treat-
ment of acute watery diarrhoea in children with severe mal-
nutrition. The calculated osmolarity was 302 mosmol/L for
both the solutions, because the PHGG does not change the
osmolarity. The study was conducted at the Dhaka Hospital
of the International Centre for Diarrhoeal Disease Research
Bangladesh (icddr,b) from July 2007 to December 2009.
Study population
Children of either sex, aged 6 months to 36 months, pre-
senting with acute watery diarrhoea (defined as 3 or more
watery stool for 24 hours) of <7 days duration, some or se-
vere dehydration, weight for length < −3 Z-score/weight
for age < −3 Z- score, were eligible for the study. The chil-
dren with bloody diarrhoea, severe diseases (severe sepsis,
meningitis, severe pneumonia with respiratory distress re-
quiring intensive care and ancillary support such as O2 in-
halation, oropharyngeal suction etc.) were excluded from
the study. Written informed consent was obtained from
parents/legal guardian of each of the participating chil-
dren. The study protocol was approved by the Research
Review Committee (RRC) and Ethical Review Committee
(ERC) of icddr,b.
Sample size
Based on the results of a clinical trial [13] of ORS solution
in severely malnourished children with acute watery diar-
rhoea (the mean ± SD duration of diarrhoea was 66.4 ±
32.3 h), we anticipated a 25% reduction in diarrhoea
duration in children receiving PHGG-added ORS. Consid-
ering 5% level of significance and 80% power and 5% drop
out the sample size was estimated to be 63 in each group.
Randomization
After eligibility was confirmed the patient was randomized
to receive, either i) modified WHO-ORS plus PHGG
(study group) or ii) modified WHO-ORS alone (control
group). An experienced statistician at icddr,b, not involved
in the study, prepared the randomization list using the
randomization table. The name of intervention was indi-
cated on a slip of paper, kept inside the sealed envelope.
The sealed envelopes were supplied to the pharmacists of
Dhaka Hospital, not involved in the study in any way, to
prepare the solutions, which were identical in appearance
and similar in taste. They labeled the bottles with the
assigned random number, patient’s name, and hospital
registration number and handed them over to the study
staff for ready to drink. PHGG is a white powder com-
pletely soluble in water and does not make the change of
color and taste of the solution at the concentration used
in oral rehydration solution [6]. After 12 hours, unused
ORS was measured and discarded and a fresh bottle of
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Oral Rehydration Therapy (ORT) was continued until
resolution of diarrhoea but up to a maximum of 7 days.
The children with some dehydration was randomized im-
mediately after admission and children with severe dehy-
dration were given intravenous (IV) fluid immediately
after admission and was randomized as soon as the child
was out of hypovolaemic shock (improvement of alert-
ness, able to drink and countable radial pulse) and the
signs of severe dehydration has disappeared but not later
than 4 hours. After 4 hours, if the children still have signs
of severe dehydration were excluded from the study.
Baseline information
Children fulfilling the eligibility criteria were admitted to
the Research Ward of the Dhaka Hospital of icddr,b and
stayed in the hospital throughout the study period until dis-
charged. One of the investigators or research physician
reconfirmed children’s eligibility for inclusion in the study.
She/he took a detailed medical history of the enrolled chil-
dren to determine the duration of and type of diarrhoea
and its frequency; duration and frequency of vomiting; and
presence of other symptoms such as fever, feeding difficul-
ties, and treatment received for the illness before admission;
and performed a thorough physical examination including
assessment of dehydration according to the modified
WHO guidelines (14) used in icddr,b and also the anthro-
pometry performed and recorded.
Laboratory tests
Laboratory tests included blood for determination of
Hct%, total and differential WBC count, serum total pro-
tein, albumin and glucose, and serum electrolytes; stool
for microscopy (including Cryptosporidium and Giardia
lamblia) and culture for Shigella, Salmonella, Vibrio cho-
lerae, and ELISA for rotavirus and urine microscopy were
performed on admission. Serum electrolytes were re-
peated after 24 hours and 48 hours, if indicated after initi-
ation of the ORS therapy. Other relevant investigations
such as chest X-ray and blood culture were done, only if
clinically indicated.
Case management
We followed the standardized protocol for management
of severely malnourished children used at icddr,b Dhaka
Hospital [2,3]. Dehydration was assessed according to the
modified WHO guidelines [14,15] followed in the hospital.
In children with some dehydration, the fluid deficit was
corrected with the assigned ORS in an amount 10 ml/kg/
hour for the first two hours, then 5 ml/kg/hr until the def-
icit was corrected. In addition, ongoing stool losses were
replaced with the assigned ORS 5–10 ml/kg after each
watery stool. For high purging patient, the ORS intake
was adjusted according to the on going stool loss. ORStherapy was continued until diarrhoea ceased. Children with
severe dehydration were initially rehydrated with IV fluid
(Cholera Saline containing Na 133 mmol/L, Cl 98 mmol/L,
K 13 mmol/L, acetate equivalent to HCO3 48 mmol/L) until
the patient was out of hypovolaemic shock (shock in these
children was identified by altered consciousness/ lethargy,
cold, clammy hands and feet, uncountable or absent radial
pulse etc.) or disappearance of signs of severe dehydration.
Then the rest of the rehydration was performed with ORS
as for rehydration in patients with some dehydration, as de-
scribed above. Children without apparent extra-intestinal in-
fection received Injection ampicillin 100 mg/kg/24 h in 3
divided doses and Injection gentamicin 5 mg/kg/24 h in 2
divided doses for 5 days (as per protocol for management of
children with severe malnutrition in icddrb and WHO).
Children with lower respiratory tract infection received In-
jection Ceftriaxone 75 mg /kg/day for 5 days, and those with
cholera initially diagnosed by positive Dark-field microscopy
received syrup Azithromycin 20 mg/kg once within 20 mi-
nutes of randomization.
Mothers were advised to continue breastfeeding. Sup-
plementary feeding with a locally prepared therapeutic
diet of formula milk (cow’s milk, rice powder mixture, en-
ergy 70 kcal/100 ml) was given in an amount of 10 ml/kg
for each feed two hourly for day 1 and increased slowly up
to 150 Kcal/kg/day over 7 days according to demand. If
the child had poor appetite, or was weak, or had painful
stomatitis or glossitis, food was delivered through naso-
gastric tube until able to take food orally. Additionally,
semisolid cooked foods (mixture of rice, lentil, vegetables
etc.) were given to older children during convalescent and
rehabilitation phase.
All children were given vitamins and minerals as per
protocol [2,3]. Hypoglycemia (blood glucose <3.0 mmol/L)
was managed with 50 ml 10% glucose orally or by nasogas-
tric tube. Injection 25% glucose 2 ml/kg was given I/V, if the
level of blood glucose was below 1.5 mmol/L. Hyponatrae-
mia (serum sodium <115 mmol/L with or without symp-
toms) was managed with hypertonic saline such as Injection
3% NaCl at the rate of 12 ml/kg I/V slowly over 4 hours.
Measurements
Fluids intakes (IV, ORS and water)
IV fluid was infused through a calibrated soluset, the
amount infused was recorded every 6 hours if the patient
was receiving I/V fluid; ORS was supplied after measuring
with a calibrated cylinder and the amount of intake was
noted every 6 hours, if any left over that was deducted
from previous offer. Water intake was also measured in a
similar way.
Output (stool, urine and vomitus)
Stool was collected in a bucket of known weight beneath
the cholera cot with a central hole and measured every
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Urine was collected by pediatric urine collector (PUC bag)
and measured with a calibrated cylinder in ml. Vomitus
was collected in a pre-weighed bowl and measured with
an electronic scale.
The children were offered a defined food of known cal-
orie after measuring with an electronic scale of precision
of 1 g. Any left over was measured and subtracted from
the amount offered and amount ingested was recorded
every 6 hours. Nude body weight was measured at admis-
sion, after rehydration and every 6 hours until recovery
from diarrhoea and then at the end of every 24 hours and
at discharge. Clinical evaluation was performed every
morning and evening. Resolution of diarrhoea was defined
as the passage of two consecutive soft/formed stool or no
stool for 12 hours. Therapeutic success was defined as the






58 analysed for duration of 
diarrhea (per protocol analyses)  
5 withdrawn before  diarrhoea 
stopped:
-3 transferred to special care unit
(SCU) for severe hypokalaemia  
(serum potassium <2.0 mmol/L
- 1 transferred to SCU for severe  
pneumonia
- 1 withdrawn by parents
Modified WHO-ORS, (n=63)
included in intention to treat 
analyses (ITT)
54 analysed for duration to attain 
weight for length 80% of median 
(per protocol analyses)  
4 withdrawn by parents after 
diarrhea stopped
Figure 1 Trial profile.treatment. Duration of diarrhoea was calculated in hours
from the time of randomization to the last watery or loose
stool within 7 days. Children were considered withdrawn
from the study if their parents or legal guardian withdrew
consent, or transferred to other units of the hospital for
treatment of any complications; data (intakes and outputs)
of such patients up to the time of withdrawal were in-
cluded in the analysis (intent to treat analysis). Data of the
children who failed to recover within seven days (study
period) were also included in the analysis for a maximum
of seven days; those were labeled as therapeutic failures
and were treated in the hospital until recovery. All patients
after cessation of diarrhoea and control of other associated
infection were transferred to nutrition rehabilitation unit.
The children were discharged from the hospital as soon as
they attained weight for height measurement of 80% of




- 52 did not meet criteria (50 did 
not meet the criteria for severe 
malnutrition, 2 suspected for 
severe sepsis).
- Parents refused consent (n=12)
       
57 analysed for duration of diarrhoea (per 
protocol analyses)   
6 withdrawn before diarrhoea 
stopped:
-3 transferred to SCU for 
severe hypokalaemia (serum 
potassium <2.0 mmol/L)  
-1 transferred to SCU for 
severe pneumonia
-2 withdrawn by parents
Modified WHO-ORS plus 
PHGG 15 g/L,
(n=63) included in intention to 
analyses (ITT)
5 withdrawn by parents after 
diarrhoea stopped
52 analysed for duration to 
attain weight for length 80% of 
median (per protocol analyses)    
Table 1 Admission characteristics of study patients (values are mean ± SD or numbers)
Variables Modified WHO -ORS (n = 63) Modified WHO-ORS + PHGG (n = 63)
Age (month) 18. 3 ± 11. 26 17. 8 ± 10
Gender (male/female) 32/31 35/27
Admission Weight (kg) 6.0 ± 1.33 5.84 ± 1.13
Weight for age percent median 54. 9 ± 6.7 54.9 ± 5.38
Weight for length percent median 70.9 ± 5.3 70.8 ± 5.6
Weight for age Z score −4.38 ± .68 −4.31 ± 0.63
Weight for length Z score −3.14 ± 1.88 −2.76 ± 2.46
Presence of bi-pedal edema 46/63 (73%) 49/63(78%)
Serum Albumin (g/L) 39.7 ± 5.57 39.3 ± 6.12
Serum sodium (mmol/L) 140 ± 6.7 140 ± 5.8
Serum potassium (mmol/L) 3.54 ± 1.0 3.6 ± 1.0
Serum chloride (mmol/L) 105 ± 8.0 106 ± 7.0
SerumTCO2 (mmol/L) 16.4 ± 4.2 15.8 ± 3.6
Duration of diarrhoea before admission (hours) 39 ± 18.2 40.0 ± 15.68
Number of stool in last 24 hours. 14.36 ± 6.00 14.02 ± 6.09
Duration of vomiting before adm. (hours) 35.9 ± 18.10 38.6 ± 16.2
No. of vomit in last 24 hrs 7.7 ± 4.1 7.4 ± 3.4
Dehydration status on admission (Some/ Severe) 57/6 55/8
Breastfed prior to illness 43/63 (69%) 48/63(76%)
Stool pathogens
Vibrio cholera 3/63 4/63
Rota virus 4/63 5/63
None identified* 56/63 54/63
*Stool tests to identify diarrhoeagenic Escherichia coli were not performed.
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ing criteria used for the severely malnourished children
with diarrhoea attending the icddr,b, Dhaka Hospital). After
discharge, they were also asked to attend our existing nutri-
tional follow up unit (NFU) for further follow up. These fol-
low ups were not recorded for analyses in this study.Clinical outcome
Main outcome measures were duration of diarrhoea, pro-
portion of patient recovered within 72 hours, daily stoolTable 2 Comparison of outcome variables between two treat
Variables Modified WHO-OR
(n = 63)
Duration of diarrhoea (hours) after admission 75 ± 39
Number of children stopped diarrhoea within 72 hours 19/63(30%)
Time required to attain 80% of the median weight
for length (days)
5.7 ± 2.8
Number of children with ORS failure/Requirement
of unscheduled IV therapy
3/63 (5%)
*Relative Risk (RR) (95% confidence interval).
Values are mean ± SD or numbers (%).output and recovery from severe malnutrition (Attaining
weight for length of 80% median or ≥ −2 Z-score without
edema).Statistical methods
All data were entered into microcomputer and analyzed
using the soft ware ‘statistical package for Social Science
(SPSS PC+ version 10, Chicago, IL). Continuous variables
were compared between groups with student’s t-test and
nonparametric tests, categorical variables were comparedment groups
S Modified WHO-ORS + PHGG
(n = 63)
Mean difference (95% CI) p-value
57 ± 31 −18(−30, −4) 0.01
29/63(46%) 0.66(0.41 to 1.04)* 0.06
4.5 ± 2.6 −1.2 (−2.27, −0.14) 0.027
4/63 (6.34%) 0.75(0.17 to 3.22)* 0.69
Figure 2 Kaplan Meier survival curves for duration of diarrhoea.
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for the duration of diarrhoea and compared with log rank
test; a p value <0.05 was considered as significant.
Results
Recruitment and participant flow
In total 190 children attending the icddr,b Dhaka Hospital
for treatment were screened for this study (Figure 1), of
whom 126 children were randomized; 63 received modified
WHO- ORS plus PHGG 15 g/L (study group) and 63 re-
ceived modified WHO-ORS alone (control group). ReasonsTable 3 Comparison of output data (stool and urine) of the st
Variables Modified WHO- ORS Modified
Stool weight(g) 1st 24 hour 949.11 ± 544.33 854.03 ± 53
Stool weight(g) 2nd 24 hour 761.26 ± 631.64 579.84 ± 46
Stool weight (g) 3rd 24 hour 495.73 ± 487.61 385.87 ± 45
Urine vol. (ml) 1st 24 hour 237.75 ± 125.79 276.75 ± 18
Urine vol. (ml) 2nd 24 hour 395.17 ± 213.51 458.14 ± 24
Urine vol. (ml) 3rd 24 hour 397.50 ± 182.66 489.13 ± 30
SD, standard deviation; CI, confidence interval.
Data are mean ± SD.for non-randomization included failure to meet study inclu-
sion criteria (n = 52; 50 did not meet the criteria of severe
malnutrition and 2 suspected for severe sepsis) and refusal
of parents consent (n = 12). During the study period after
randomization, 6 patients were withdrawn from the study
group before diarrhoea stopped. Of them 4 were trans-
ferred to special care unit (SCU) for management severe
hypokalaemia (n = 3) and severe pneumonia (n = 1); with-
drawn by parents (n = 2). In the control group, similarly 5
patients were withdrawn before diarrhoea stopped. Of
them 4 were transferred to special care unit (SCU) forudy patients
WHO- ORS + PHGG Mean difference (95% CI) P - Value
2.15 −95.07(−284.90, 94.74) 0.32
6.01 −181.42(−377.16, 14.30) 0.06
4.09 −109.86(−277.30, 57.57) 0.19
9.11 38.99(−20.24, 98.23) 0.19
6.25 62.96(−24.04, 149.98) 0.15
4.20 91.63(−10.66, 193.92) 0.07
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monia (n = 1); withdrawn by parents (n = 1). Therefore, 57
patients in the study group and 58 in the control group
were included for analysis (per protocol analysis) for com-
parison of the duration of diarrhoea. During the whole
study period before the patients attained 80% of the median
weight for length without edema, 11 patients were with-
drawn from the study in study group, of them 6 withdrawn
before diarrhoea stopped (mentioned above) and 5 were
withdrawn by parents after diarrhoea stopped. In the con-
trol group, 9 patients were withdrawn from the study be-
fore they attained 80% of median weight for length without
edema, of them 5 withdrawn before diarrhoea stopped
(mentioned above), and 4 withdrawn by parents after diar-
rhoea stopped. So, 52 patients in the study group and 54 in
control group were included for analysis (per protocol ana-
lysis) for comparison of duration to attain 80% of the me-
dian weight for length without edema.
Baseline clinical characteristics such as age, body
weight, nutritional status, duration of diarrhoea, dehy-
dration status, breastfeeding status, and biochemical pa-
rameters, stool pathogen etc. were comparable between
the treatment groups (Table 1). The mean duration of
diarrhoea (h) was significantly shorter in children of the
study group (p = 0.01) compared with children of the
control group (Table 2). The proportion of children re-
covered from diarrhoea within 72 hours was more in
the study group (p = 0.06), although the difference was
not statistically significant (Table 2). The Kaplan –Meier
Survival curve analysis for the duration of diarrhea also
showed a similar trend towards reduced duration of
diarrhoea (Figure 2) in children of the study group (p =
0.045, log rank test). The mean time (day) to attain
weight for length 80% of NCHS median without edema
was shorter in the study group (p = 0.027) compared to
the control group (Table 2). There was a trend in stool
reduction in children receiving ORS with PHGG, espe-
cially during the 2nd 24 hour (p = 0.06), although the dif-
ference was not statistically significant (Table 3). TheTable 4 Comparison of intake data (ORS, milk formula and w
Variables Modified WHO- ORS Modified
Ors intake (ml) 1st 24 hour 825.95 ± 373.11 747.06 ± 3
Ors intake (ml) 2nd 24 hour 609.84 ± 448.52 553.01 ± 4
Ors intake (ml) 3rd 24 hour 396.98 ± 419.01 307.01 ± 3
Milk formula (ml) 1st 24 hour 590.39 ± 111.78 597.45 ± 1
Milk formula (ml) 2nd 24 hour 609.01 ± 108.37 610.44 ± 1
Milk formula(ml) 3rd 24 hour 621.87 ± 108.90 619.23 ± 1
Water intake (ml) 1st 24 hour 308.27 ± 122.16 344.21 ± 1
Water intake (ml) 2nd 24 hour 335.35 ± 120.30 330.09 ± 1
Water intake (ml) 3rd 24 hour 315.72 ± 121.37 381.73 ± 1
SD, standard deviation; CI, confidence interval.
Data are mean ± SD.mean urine output (ml) was similar in the treatment
groups (Table 3).
ORS intake was reduced in children of study group,
however the differences were not statistically significant
(Table 4). Other intakes (milk formula and water) were
similar in both groups except increased mean water intake
(ml) in the study group during the 3rd 24 hour (p = 0.02)
which was statistically significant (Table 4).
Discussion and conclusion
The study showed that PHGG when added to oral rehydra-
tion solution enhanced early recovery of acute diarrhoea in
severely malnourished children in terms of reducing the
duration of diarrhoea and stool output. Similar results were
also reported when PHGG added ORS was used in the
treatment of acute diarrhoea in non severely malnourished
children [6], PHGG added comminuted chicken meat diet
used in the treatment of persistent diarrhoea in children [7]
and PHGG added ORS used in the treatment of adult chol-
era [16]. It has also been shown that PHGG added ORS in
this study enhanced weight gain. So, the findings of the pre-
vious studies [6,7,16] and current study demonstrate that
the beneficial effects of PHGG in the treatment of acute or
persistent diarrhoea are consistent. It has also been shown
beneficial effect of other unabsorbed carbohydrates (amylase
resistant starch derived from maize) added ORS in the treat-
ment of acute diarrhoea in children and adult cholera
[17,18]. In Bangladesh, soluble fiber containing fruits (such
as green plantain and semi ripe wood apple) are traditionally
used as an anti-diarrhoeal food, with an expectation of bene-
ficial effect in recovery. Recently one clinical study [19] in
icddr,b examined the effect of cooked green banana (one
variety used in Bangladesh as a vegetable) and pectin in the
treatment of persistent diarrhoea in children. Both pectin
and green banana have been shown to be beneficial in the
treatment of persistent diarrhoea in children in terms of
reducing the duration of diarrhoea and stool weight. Simi-
lar results have also been found in a community based
trial, with green banana-supplemented diet in the home-ater) by study patients
WHO- ORS + PHGG Mean difference (95% CI) P – Value
88.30 −78.88(−213.17, 55.39) 0.24
46.84 −56.82(−214.70, 101.05) 0.47
72.11 −89.96(−230.35, 50.41) 0.20
01.26 7.05(−32.36, 46.48) 0.72
41.86 1.42(−46.18, 49.03) 0.95
34.16 −2.63(−52.59, 47.32) 0.91
44.40 35.93(−13.44, 85.31) 0.15
33.65 −5.26(−53.28, 42.75) 0.82
54.52 66.00(9.22, 122.79) 0.02
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(>7 days duration) diarrhoea in children [20].
The anti-diarrhoeal effect of soluble fiber/unabsorbed
carbohydrate is thought to be mediated through their bac-
terial fermentation in colon, resulting in production of
SCFAs. In the colon SCFAs facilitate absorption of sodium
chloride and water [10,21], they also serve as an important
source of energy for the colonocytes [22], and stimulate epi-
thelial cell proliferation and exert a trophic effect on the co-
lonic as well as small bowel mucosa [23,24].
The major limitation of the study was accuracy in collect-
ing stool from female children. There might be some
contamination of urine with stool. Careful recording of con-
tamination was not possible. However, the distribution of fe-
male children in both the groups was similar in number due
to the proper randomization effect that might take care for
the comparability of the stool weight between the two
groups. Other limitation of the study was that the stool test
for diarrhoeagenic Eschericia coli was not performed and so
majority of the unidentified pathogen in stool test might be
diarrhoeagenic Eschericia coli. However, that should not in-
fluence the study results.
Despite the efficacy of ORS in correcting dehydration and
preventing mortality that has already been established [25],
its use has not yet achieved the widespread popularity, as it
was initially expected [26,27]. Although this may be due to
the lack of knowledge and appreciation of the effect of ORS,
caregivers/parents in the community have been reluctant to
use ORS as it does not substantially reduce diarrhoea. So,
the present study was one of the efforts to find out an im-
proved version of ORS that will reduce diarrhoea. To find
out the best effective amylase resistant and fermentable car-
bohydrates for use in ORS, more clinical studies are to be
carried out in future. Further more research on the issue of
improved version of ORS should continue.
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